Quantcast
 
Read Larry Connors' blogShort Term Trading Strategies


 

Oxford Nanopore Collaborators Win $1.8 Million In NIH Grants

Thu. October 15, 2009; Posted: 10:34 AM
Stocks RSS

Look up the PowerRating of TDCX and see how it has performed over the past week as well as the current proprietary PowerRating.

OXFORD, United Kingdom, Oct 15, 2009 (BUSINESS WIRE) -- TDCX | Quote | Chart | News | PowerRating -- Oxford Nanopore Technologies congratulates our collaborators Professor Mark Akeson and Professor David Deamer of the University of California, Santa Cruz (UCSC) on receiving a grant of $1.1 million, and Professor Jene Golovchenko of the University of Harvard on receiving $745,000 following on from a previous grant of $6.5 million. These grants were made under the US National Human Genome Research Institute (NHGRI) "$1,000 Genome Sequencing Technology Development" grant programme.

Oxford Nanopore is developing a platform technology for the direct electrical analysis of single molecules. The Company's lead application is DNA sequencing, however the platform may also be developed for the analysis of other analytes. In 2008 Oxford Nanopore announced agreements with Harvard and UCSC whereby Oxford Nanopore exclusively licensed nanopore sensing methods that had been developed at the institutions and also agreed to fund further research in their laboratories. This augmented the existing relationship with the University of Oxford through the Company's founder Professor Hagan Bayley and the Company's internal expertise and intellectual property.

Oxford Nanopore's first generation of nanopore-based DNA sequencing technology uses a processive enzyme to cleave individual bases from a DNA strand. As DNA bases pass through a protein nanopore in sequence, they are identified by measuring characteristic disruptions in a current through the nanopore.

An iteration of this method may identify DNA bases on a long, intact strand of DNA as it passes through the protein nanopore. A key challenge for the development of this technology is the speed at which DNA passes through the pore; typically this is too fast to identify individual DNA bases on a strand. Professors Deamer and Akeson at UCSC have been developing a method of controlling the passage of DNA using a polymerase enzyme coupled with the nanopore so that this method might be developed into an industrial DNA sequencing system.

A further development in nanopore sequencing technology would be the creation of nanopores from man made materials, called "solid-state" nanopores. This technology would be expected to deliver a further step-change in improved manufacturing costs and sequencing performance. Professor Jene Golovchenko's Harvard laboratory has researched solid state nanopores for many years, with collaborator and nanopore pioneer Professor Dan Branton.

Dr Gordon Sanghera, CEO of Oxford Nanopore Technologies, said: "We would like to congratulate Professors Akeson, Deamer and Golovchenko for these well-deserved grants. The UCSC lab is recognised as having world-leading expertise in the control of DNA molecules in protein nanopore sensing, which is a fundamental challenge for the second generation of nanopore sequencing technology. Researchers in the Harvard lab are recognised as the pioneers of solid-state nanopores, which is the ultimate goal for nanopore sequencing. We are proud to be working with these talented and dedicated teams on our current and future generations of nanopore technology."

Notes to Editors

Oxford Nanopore Technologies is developing a platform technology for the direct electrical analysis of single molecules. The lead application is DNA sequencing but the platform may also be developed for other analytes including proteins and small molecules such as metabolites

In 2008 Oxford Nanopore announced the creation of a Technology Advisory Board and collaborations with the world's leading nanopore researchers, responsible for the earliest and ongoing nanopore discoveries and generation of a broad patent portfolio. As a result, Oxford Nanopore has exclusive rights around the world to more than 150 fundamental patents and patent applications in a comprehensive range of nanopore sensing technologies, spanning both biological and solid-state technology. Click here for more details Oxford Nanopore's collaborations with UCSC and Harvard.

Click here for the UCSC announcement, here for the NIH/NHGRI announcement. Click here for details on the Harvard research group and here for details of their previous grant.

For more details on Oxford Nanopore's Technology Advisory Board click here or click here for more information about the company.

SOURCE: Oxford Nanopore Technologies

Oxford Nanopore Technologies 
Zoe McDougall, +44 (0)845 034 7900
For full details for TDCX click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [TDCX]
  UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
* Attendance is strictly limited and are filled on a first-come, first-served basis.
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.